help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on October 3, 2002
Molecular Endocrinology, doi:10.1210/me.2001-0305
A more recent version of this article appeared on December 1, 2002
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
16/12/2840    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pickett, C. A.
Right arrow Articles by Gutierrez-Hartmann, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pickett, C. A.
Right arrow Articles by Gutierrez-Hartmann, A.

Submitted on November 12, 2001
Accepted on September 12, 2002

Role of Specific PKC Isozymes in Mediating EGF, TRH and Phorbol Ester Regulation of the rPRL Promoter in GH4/GH4C1 Pituitary Cells

Cheryl A. Pickett1*, Nicole Manning1, Yoshiko Akita1, and Arthur Gutierrez-Hartmann1

1 Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, WA (C.A.P.); Department of Medicine and of Biochemistry, Biophysics and Genetics, Program in Molecular Biology and Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO (N.M. and A.G.H.); Department of Molecular Cell Physiology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan (Y.A.)

* To whom correspondence should be addressed. E-mail: cpickett{at}u.washington.edu.

Epidermal growth factor (EGF) and TRH(TRH) both produce enhanced PRL(PRL) gene transcription and PRL secretion in GH4 rat pituitary tumor cell lines. These agents also activate protein kinase C (PKC) in these cells. Previous studies have implicated the PKC{epsilon} isozyme in mediating TRH induced PRL secretion. However, indirect studies using phorbol ester down-regulation to investigate the role of PKC in EGF and TRH induced PRL gene transcription have been inconclusive. In the present study, we examined the role of multiple PKC isozymes on EGF and TRH induced activation of the PRL promoter by utilizing general and selective PKC inhibitors and by expression of genes for wild type and kinase negative forms of the PKC isozymes. Multiple non-selective PKC inhibitors, including staurosporine, bisindolylmaleimide I, and Calphostin C, inhibited both EGF and TRH induced rPRL promoter activity. TRH effects were more sensitive to Calphostin C, a competitive inhibitor of DAG, while Go 6976, a selective inhibitor of Ca2+-dependent PKC's, produced a modest inhibition of EGF but no inhibition of TRH effects. Rottlerin, a specific inhibitor of the novel nPKC{delta} isozyme, significantly blocked both EGF and TRH effects. Overexpression of genes encoding PKC's {alpha}, ßI, ßII, {delta}, {gamma}, and {lambda} failed to enhance either EGF or TRH responses, whereas overexpression of nPKC{eta} enhanced the EGF response. Neither stable nor transient overexpression of nPKC{epsilon} produced enhancement of EGF or TRH induced PRL promoter activity, suggesting that different processes regulate PRL transcription and hormone secretion. Expression of a kinase inactive nPKC{delta} construct produced modest inhibition of EGF mediated rPRL promoter activity. Taken together these data provide evidence for a role of multiple PKC isozymes in mediating both EGF and TRH stimulated PRL gene transcription. Both EGF and TRH responses appear to require the novel isozyme, nPKC{delta}, while nPKC{eta} may also be able to transmit the EGF response. Inhibitor data suggests that the EGF response may also involve Ca2+-dependent isozymes while the TRH response appears to be more dependent on DAG.
Key words: EGF • TRH • PKC • signal transduction • PRL • gene regulation




This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. Vlotides, E. Siegel, I. Donangelo, S. Gutman, S.-G. Ren, and S. Melmed
Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands
Cancer Res., August 1, 2008; 68(15): 6377 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. McGahren-Murray, N. H.A. Terry, and K. Keyomarsi
The Differential Staurosporine-Mediated G1 Arrest in Normal versus Tumor Cells Is Dependent on the Retinoblastoma Protein
Cancer Res., October 1, 2006; 66(19): 9744 - 9753.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Luo, N. Yano, and J. Z. Q. Luo
The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E889 - E899.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Klausen, T. Tsuchiya, J. P. Chang, and H. R. Habibi
PKC and ERK are differentially involved in gonadotropin-releasing hormone-induced growth hormone gene expression in the goldfish pituitary
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1625 - R1633.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. Sen, J. Browning, E. K. Inskeep, P. Lewis, and J. A. Flores
Expression and Activation of Protein Kinase C Isozymes by Prostaglandin F2{alpha} in the Early- and Mid-Luteal Phase Bovine Corpus Luteum
Biol Reprod, February 1, 2004; 70(2): 379 - 384.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society